Ad is loading...
QCLVX
Price
$36.31
Change
-$0.13 (-0.36%)
Updated
Nov 15 closing price
RMEBX
Price
$58.52
Change
-$0.52 (-0.88%)
Updated
Nov 15 closing price
Ad is loading...

QCLVX vs RMEBX

Header iconQCLVX vs RMEBX Comparison
Open Charts QCLVX vs RMEBXBanner chart's image
Federated Hermes MDT Large Cap Value C
Price$36.31
Change-$0.13 (-0.36%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R2E
Price$58.52
Change-$0.52 (-0.88%)
VolumeN/A
CapitalizationN/A
QCLVX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
QCLVX vs. RMEBX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QCLVX is a Buy and RMEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 104B vs. QCLVX (1.38B). RMEBX pays higher dividends than QCLVX: RMEBX (1.54) vs QCLVX (0.41). QCLVX was incepted earlier than RMEBX: QCLVX (7 years) vs RMEBX (10 years). QCLVX is a more actively managed with annual turnover of: 95.00 vs. RMEBX (25.00). RMEBX has a lower initial minimum investment than QCLVX: RMEBX (250) vs QCLVX (1500). QCLVX annual gain was more profitable for investors over the last year : 36.36 vs. RMEBX (21.12). RMEBX return over 5 years is better than : 43.89 vs. QCLVX (33.36).
QCLVXRMEBXQCLVX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years10 years-
Gain YTD25.51116.258157%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B104B1%
Annual Yield % from dividends0.411.5427%
Returns for 1 year36.3621.12172%
Returns for 3 years0.6614.924%
Returns for 5 years33.3643.8976%
Returns for 10 yearsN/A63.64-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IRM114.881.76
+1.56%
Iron Mountain
BBDC9.950.06
+0.61%
Barings BDC
MAC19.270.04
+0.21%
Macerich Company (The)
FATE2.02-0.06
-2.88%
Fate Therapeutics
NRXS3.15-0.12
-3.67%
Neuraxis